2/6
10:08 am
plse
Pulse Biosciences (NASDAQ:PLSE) was given a new $30.00 price target on by analysts at Mizuho.
High
Report
Pulse Biosciences (NASDAQ:PLSE) was given a new $30.00 price target on by analysts at Mizuho.
2/5
07:00 pm
plse
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
High
Report
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
2/4
04:05 pm
plse
Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
High
Report
Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
2/3
07:23 am
plse
Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium [Yahoo! Finance]
Low
Report
Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium [Yahoo! Finance]
2/3
07:00 am
plse
Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
Low
Report
Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
1/30
07:00 am
plse
Pulse Biosciences (NASDAQ:PLSE) is now covered by analysts at Mizuho. They set an "outperform" rating and a $25.00 price target on the stock.
Low
Report
Pulse Biosciences (NASDAQ:PLSE) is now covered by analysts at Mizuho. They set an "outperform" rating and a $25.00 price target on the stock.
1/12
05:45 am
plse
How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh [Yahoo! Finance]
Low
Report
How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh [Yahoo! Finance]
1/9
07:16 am
plse
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors [Yahoo! Finance]
Low
Report
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors [Yahoo! Finance]
1/9
07:00 am
plse
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
Low
Report
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
1/6
07:32 am
plse
Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium [Yahoo! Finance]
Low
Report
Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium [Yahoo! Finance]
1/6
07:00 am
plse
Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
Low
Report
Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
12/29
05:41 pm
plse
Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/29
04:05 pm
plse
Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/20
07:19 pm
plse
Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial [Yahoo! Finance]
Low
Report
Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial [Yahoo! Finance]
12/19
04:05 pm
plse
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/19
12:40 pm
plse
PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial [Yahoo! Finance]
Low
Report
PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial [Yahoo! Finance]
12/18
07:40 am
plse
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation [Yahoo! Finance]
12/18
07:00 am
plse
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
Low
Report
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
12/9
07:00 am
plse
Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology
Low
Report
Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology
11/21
04:05 pm
plse
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)